Furthermore, there were no statistically significant changes in the use of only insulin therapy during the follow-up among all patient groups, except those with T2D + CVD + AMD, who showed an increasing trend in the use of only insulin therapy (Table 2). The gene discussed is INS; the disease is type 2 diabetes mellitus.